2026-04-30T03:50:59Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/160872025-04-23T08:08:05Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19609

00925njm 22002777a 4500 dc Linkevicius, Marius author Bonnin, Rémy A author Alm, Erik author Svartström, Olov author Apfalter, Petra author Hartl, Rainer author Hasman, Henrik author Roer, Louise author Räisänen, Kati author Dortet, Laurent author Pfennigwerth, Niels author Hans, Jörg B author Tóth, Ákos author Buzgó, Lilla author Cormican, Martin author Delappe, Niall author Monaco, Monica author Giufrè, Maria author Hendrickx, Antoni PA author Samuelsen, Ørjan author Pöntinen, Anna K author Caniça, Manuela author Manageiro, Vera author Oteo-Iglesias, Jesus author Perez-Vazquez, Maria author Westmo, Karin author Mäkitalo, Barbro author Palm, Daniel author Monnet, Dominique L author Kohlenberg, Anke author 2023-05 Whole genome sequencing data of 874 Escherichia coli isolates carrying bla NDM-5 from 13 European Union/European Economic Area countries between 2012 and June 2022 showed the predominance of sequence types ST167, ST405, ST410, ST361 and ST648, and an increasing frequency of detection. Nearly a third (30.6%) of these isolates were associated with infections and more than half (58.2%) were predicted to be multidrug-resistant. Further spread of E. coli carrying bla NDM-5 would leave limited treatment options for serious E. coli infections. Euro Surveill. 2023 May;28(19):2300209. 10.2807/1560-7917.ES.2023.28.19.2300209 1560-7917 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 37166762 http://hdl.handle.net/20.500.12105/16087 Carbapenem-resistant Enterobacterales Escherichia coli NDM-5 Carbapenemase Cross-border import Surveillance Whole genome sequencing Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union/European Economic Area, 2012 to June 2022